| A probiotic modulates the microbiome and immunity in multiple sclerosis SK Tankou, K Regev, BC Healy, E Tjon, L Laghi, LM Cox, P Kivisäkk, ... Annals of neurology 83 (6), 1147-1161, 2018 | 220 | 2018 |
| Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study Y Zhao, T Wang, R Bove, B Cree, R Henry, H Lokhande, ... NPJ digital medicine 3 (1), 135, 2020 | 41 | 2020 |
| Clostridium bolteae is elevated in neuromyelitis optica spectrum disorder in India and shares sequence similarity with AQP4 L Pandit, LM Cox, C Malli, A D'Cunha, T Rooney, H Lokhande, V Willocq, ... Neurology: Neuroimmunology & Neuroinflammation 8 (1), e907, 2020 | 34 | 2020 |
| Time between expanded disability status scale (EDSS) scores J Zurawski, BI Glanz, A Chua, H Lokhande, D Rotstein, H Weiner, ... Multiple sclerosis and related disorders 30, 98-103, 2019 | 32 | 2019 |
| Relapse recovery in multiple sclerosis: effect of treatment and contribution to long-term disability MG Sotiropoulos, H Lokhande, BC Healy, M Polgar-Turcsanyi, BI Glanz, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 7 (2 …, 2021 | 19 | 2021 |
| Early predictors of clinical and MRI outcomes using least absolute shrinkage and selection operator (LASSO) in multiple sclerosis G Bose, BC Healy, HA Lokhande, MG Sotiropoulos, M Polgar‐Turcsanyi, ... Annals of neurology 92 (1), 87-96, 2022 | 15 | 2022 |
| Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases S Saxena, H Lokhande, G Gombolay, R Raheja, T Rooney, T Chitnis Scientific Reports 10 (1), 12405, 2020 | 13 | 2020 |
| Dissection of multiple sclerosis genetics identifies B and CD4+ T cells as driver cell subsets MH Guo, P Sama, BA LaBarre, H Lokhande, J Balibalos, C Chu, X Du, ... Genome Biology 23 (1), 127, 2022 | 12 | 2022 |
| Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS H Lokhande, M Rosso, S Tauhid, R Chu, BC Healy, S Saxena, C Barro, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 8 (1 …, 2022 | 8 | 2022 |
| Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes G Bose, BC Healy, S Saxena, F Saleh, A Paul, C Barro, HA Lokhande, ... Multiple Sclerosis and Related Disorders 74, 104695, 2023 | 7 | 2023 |
| Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis T Chitnis, J Foley, C Ionete, NK El Ayoubi, S Saxena, P Gaitan-Walsh, ... Clinical Immunology 253, 109688, 2023 | 6 | 2023 |
| Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects T Chitnis, BJ Kaskow, J Case, K Hanus, Z Li, JF Varghese, BC Healy, ... Frontiers in Immunology 13, 956907, 2022 | 5 | 2022 |
| Younger age at multiple sclerosis onset is associated with worse outcomes at age 50 G Bose, BC Healy, C Barro, BI Glanz, HA Lokhande, M Polgar-Turcsanyi, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (10), 1112-1119, 2022 | 5 | 2022 |
| Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis G Bose, BC Healy, C Barro, VF Moreira Ferreira, S Saxena, BI Glanz, ... Multiple Sclerosis Journal 29 (11-12), 1418-1427, 2023 | 4 | 2023 |
| Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study A Gonzalez-Martinez, G Bose, H Lokhande, S Saxena, BC Healy, ... Journal of Neuroinflammation 20 (1), 136, 2023 | 4 | 2023 |
| Development of a custom multivariate proteomic serum based assay for association with radiographic and clinical endpoints in MS T Chitnis, M Becich, R Bove, BAC Cree, V Gehman, R Gomez, ... Mult Scler, 148-148, 2020 | 4 | 2020 |
| Clinical validation study results of a multivariate proteomic serum based assay for disease activity assessments in multiple sclerosis T Chitnis, J Foley, C Ionete, N El Ayoubi, S Saxena, P Gaitan-Walsh, ... Age (Mean±SD) 41 (12.7), 42.5-13.5, 2021 | 3 | 2021 |
| Bioinformatics analysis of miRNA sequencing data HA Lokhande MicroRNA Profiling: Methods and Protocols, 225-237, 2022 | 2 | 2022 |
| NF-κB and STAT3 activation in CD4 T cells in pediatric MOG antibody-associated disease O Corbali, S Saxena, R Patel, H Lokhande, T Chitnis Journal of Neuroimmunology 384, 578197, 2023 | 1 | 2023 |
| miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod A Gonzalez-Martinez, R Patel, BC Healy, H Lokhande, A Paul, S Saxena, ... Journal of Neuroinflammation 20 (1), 131, 2023 | 1 | 2023 |
